This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
Trimble Strengthens Forestry Division With 3LOG Acquisition
by Zacks Equity Research
3LOG Systems' solutions complement will Trimble's (TRMB) Connected Forest solutions portfolio.
Simple Market Timing Strategies That Work - August 21, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Has Agilent Technologies (A) Outpaced Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (A) Outperforming Other Computer and Technology Stocks This Year?
Agilent Launches eSight, Expands Cell Analysis Portfolio
by Zacks Equity Research
Agilent (A) unveils a multimode real-time cell analyzer, which will aid in expanding its presence in the research areas of cell biology, immunology, immuno-oncology and immunotherapy.
Tencent (TCEHY) Q2 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Tencent's (TCEHY) second-quarter 2019 results benefit from robust FinTech and Business Services revenues despite sluggish ad environment in China.
Agilent (A) Upgraded to Buy: Here's Why
by Zacks Equity Research
Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Agilent (A) Jumps: Stock Rises 6.1%
by Zacks Equity Research
Agilent (A) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Agilent (A) Earnings and Revenues Beat Estimates in Q3
by Zacks Equity Research
Agilent (A) reports solid fiscal third-quarter results driven by strength in all its revenue segments.
Agilent Technologies (A) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 5.56% and 2.85%, respectively, for the quarter ended July 2019. Do the numbers hold clues to what lies ahead for the stock?
Wall Street Tumbles Following Yield Curve Inversion
by Zacks Equity Research
Wall Street Tumbles Following Yield Curve Inversion
Stock Futures Plunge as Recession Fears Intensify
by Zacks Equity Research
U.S. stock futures plummeted ahead of trading on Wednesday after a key Treasury yield curve inverted signaling an impending recession.
Agilent (A) Gears Up for Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal third-quarter 2019 results.
Agilent Technologies (A) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Truth About Market Timing - July 30, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Agilent to Acquire BioTek, Cell Analysis Portfolio to Expand
by Zacks Equity Research
Agilent Technologies (A) enters into an agreement to buy BioTek Instruments, which is likely to strengthen its cell analysis capabilities and expand presence in life science research space.
5 Top & Flop ETF Areas of Q2
by Sanghamitra Saha
Dovish Fed comments and chances of U.S.-China trade truce kept the market steady in the second quarter. These ETF areas won and lost in the second quarter.
Electronics Testing Equipment Industry Outlook Appears Bright
by Shilpa Mete
Prospects of the Electronics - Testing Equipment industry look bright, thanks to the increasing proliferation of electronic devices in every major sector.
Agilent Announces Receipt of FDA Approval for pharmDX Assay
by Zacks Equity Research
Agilent (A) receives approval on the expanded use of its PD-L1 IHC 22C3 pharmDx assay.
Why Is Agilent (A) Up 3.9% Since Last Earnings Report?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tense About Trade War? Follow Goldman With 5 ETF Strategies
by Sanghamitra Saha
Amid heightened US-China trade tensions, investors can land up on five ETF strategies and follow the suggestions of Goldman Sachs.
Agilent (A) Misses Earnings and Revenue Estimates in Q2
by Zacks Equity Research
Agilent (A) reports weak fiscal second-quarter results due to slowing global demand in small molecule Pharma and softness in the China Food market.
Agilent Technologies (A) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of -1.39% and -2.30%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?
Agilent (A) Gears Up for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal second-quarter 2019 results.
Vishay Intertechnology (VSH) Q1 Earnings Top, Revenues Up Y/Y
by Zacks Equity Research
Vishay Intertechnology's (VSH) first-quarter results benefit from solid end market momentum and robust MOSFET, capacitors and, resistors and inductors.
Mettler-Toledo (MTD) Earnings & Revenues Top Estimates in Q1
by Zacks Equity Research
Mettler-Toledo (MTD) first-quarter 2019 results benefit from well-performing Laboratory and Industrial product lines.